CLB Research | Milton Maxwell

CLB

Core Laboratories Inc.

16.08

-0.47-2.84%

Dec 16, 4:00:02 PM EST

Upcoming Earnings

Report date

≈ -/-

Earnings Call Transcripts

This Quarter (Q1 '26)

No earnings call transcript available yet

Last Quarter (Q4 '25)

FY Q4 '25

2/4/26Feb 4, 2026

Key Stats

Market Cap

754.05M

P/E (TTM)

23.65

Basic EPS (TTM)

0.68

Dividend Yield

Recent Filings

8-K

Q1 guidance cut on Mideast unrest

3/23/26Mar 23, 2026

Core Laboratories slashed Q1 2026 guidance on March 23 due to Middle East conflict, citing client delays, supply-chain snags, and Strait of Hormuz disruptions. Revenue now eyes $119M-$123M, operating income ex-items $5.7M-$7.1M, EPS ex-items $0.05-$0.07. Reservoir Description hit hardest. Updates to follow.

10-K

FY2025 results

3/23/26Mar 23, 2026

Core Laboratories posted FY2025 revenue of $527M, up 0.5% y/y, with services climbing 3% to $399M on international growth in Europe/Africa yet held back by canceled projects from low offshore well success rates; product sales dipped 6% tracking the 6% drop in U.S. land rigs. Operating income slipped 4% to $56M (10.7% margin) as Reservoir Description margins compressed to 13% from lower high-margin rock/fluid analysis, while Production Enhancement surged 82% to 7% margins on diagnostic services. Q4 saw open-market repurchases of 363k shares at $15.74 average. Debt fell 12% to $113M with $136M revolver capacity. Escalating Middle East conflict risks supply disruptions.

8-K

Bylaws ease merger votes

3/5/26Mar 5, 2026

Core Laboratories lowered its shareholder voting threshold for mergers and change-in-control deals from 66-2/3% supermajority to simple 50%+1 majority via amended bylaws effective February 27, 2026. This board-approved tweak eases approval of major transactions. No other changes disclosed.

8-K

Q4 revenue up 7% YoY

2/4/26Feb 4, 2026

Core Laboratories reported Q4 2025 revenue of $138.3M, up 3% sequentially and 7% year-over-year, driven by strong international demand offsetting soft U.S. land. Operating income hit $15.8M with ex-items margins over 11%; full-year revenue $526.5M edged up while net debt fell $18.7M to $90.2M. Repurchased 363k shares for $5.7M; Q1 dividend $0.01/share set. Leverage at nine-year low of 1.09.

10-Q

Q3 FY2025 results

10/23/25Oct 23, 2025

Core Laboratories held Q3 revenue flat at $134.5M y/y while Reservoir Description edged down 1% to $88.2M; Production Enhancement grew 2% to $46.3M on stronger well completion diagnostics. Operating income climbed 6% y/y to $20.9M, fueled by $5.3M Aberdeen insurance gain, lower interest to $2.7M, and taxes at 20.5% effective rate; diluted EPS attributable to Core rose to $0.30 from $0.25, matching 47.1M shares. Debt fell to $114.1M net with $131.9M revolver capacity; cash hit $25.6M, FCF $20.8M (derived). Repurchased $9.8M stock YTD. Tariffs hit product margins.

About

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

CEO

Mr. Lawrence V. Bruno

IPO

9/21/1995

Website

https://www.corelab.com

Employees

3,300

Sector

Energy

Industry

Oil & Gas Equipment & Services